Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Diabetes & Metabolism
|
October 3, 2008
Fulminant type 1 diabetes in Caucasians: A report of three cases
C Moreau, D Drui, G Arnault-Ouary, et al.
Atherosclerosis
|
July 13, 2010
Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients
P Costet, M M Hoffmann, B Cariou, et al.
Diabetes & Metabolism
|
August 12, 1999
Assessment of gastric neuropathy using electrogastrography in asymptomatic diabetic patients. Correlation with cardiac autonomic neuropathy
H Mayaudon, B Bauduceau, O Dupuy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 12, 2017
Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials
L A Leiter, D Müller-Wieland, M T Baccara-Dinet, et al.
La Revue De Medecine Interne
|
April 30, 1999
[Serratia odorifera biovar 1 bronchial infection]
B Ceccaldi, B Cariou, B Soullié, et al.
Diabetes, Obesity & Metabolism
|
February 6, 2014
Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
H W Rodbard, B Cariou, B Zinman, et al.
Diabetes, Obesity & Metabolism
|
November 24, 2015
Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial
H W Rodbard, B Cariou, T R Pieber, et al.
Annales De Cardiologie Et D'Angeiologie
|
June 4, 2017
[Familial hypercholesterolemia: A largely underestimated cardiovascular risk]
J Ferrières, É Bruckert, S Béliard, et al.
Diabetes & Metabolism
|
September 19, 2019
Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials
F J Tinahones, U Laufs, B Cariou, et al.
Diabetes & Metabolism
|
September 4, 2017
Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study
B Cariou, P Guérin, C Le May, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Diabetes & Metabolism
|
October 3, 2008
Fulminant type 1 diabetes in Caucasians: A report of three cases
C Moreau, D Drui, G Arnault-Ouary, et al.
Atherosclerosis
|
July 13, 2010
Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients
P Costet, M M Hoffmann, B Cariou, et al.
Diabetes & Metabolism
|
August 12, 1999
Assessment of gastric neuropathy using electrogastrography in asymptomatic diabetic patients. Correlation with cardiac autonomic neuropathy
H Mayaudon, B Bauduceau, O Dupuy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 12, 2017
Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials
L A Leiter, D Müller-Wieland, M T Baccara-Dinet, et al.
La Revue De Medecine Interne
|
April 30, 1999
[Serratia odorifera biovar 1 bronchial infection]
B Ceccaldi, B Cariou, B Soullié, et al.
Diabetes, Obesity & Metabolism
|
February 6, 2014
Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
H W Rodbard, B Cariou, B Zinman, et al.
Diabetes, Obesity & Metabolism
|
November 24, 2015
Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial
H W Rodbard, B Cariou, T R Pieber, et al.
Annales De Cardiologie Et D'Angeiologie
|
June 4, 2017
[Familial hypercholesterolemia: A largely underestimated cardiovascular risk]
J Ferrières, É Bruckert, S Béliard, et al.
Diabetes & Metabolism
|
September 19, 2019
Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials
F J Tinahones, U Laufs, B Cariou, et al.
Diabetes & Metabolism
|
September 4, 2017
Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study
B Cariou, P Guérin, C Le May, et al.
Page
of 5